Medical device maker Abbott Laboratories is nearing a potential takeover of cancer test maker Exact Sciences Corp, Bloomberg ...

Bloomberg reports today that Abbott (NYSE: ABT) is close to a deal to acquire diagnostics developer Exact Sciences (Nasdaq:EXAS).

Scientists have created swallowable microsphere “pills” packed with engineered bacteria that can detect signs of gut disease, ...

MORE than half of men have ignored potentially worrying physical or mental health issues, according to a report. But of those ...

In this fictional tale, a skeptical physician’s scrutiny reshapes a sales rep’s journey and forces truth to prevail over glossy marketing claims.

Swapping colonoscopies for swallowing a pill packed with bacteria that can read the condition of our gut could revolutionize ...

UCLA research finds that fewer than one in four eligible younger adults completed colorectal cancer screenings after the ...

Don’t wait for the first symptom. Start regular colorectal cancer screening at 45 years old to stay proactive about your ...

Move over, colonoscopies—researchers report in ACS Sensors that they've developed a sensor made of tiny microspheres packed ...

UCLA research finds that fewer than 1 in 4 eligible younger adults completed colorectal cancer screenings after the United States Preventive Services Task Force (USPSTF) lowered the recommended ...

As screening guidelines evolve and GI care increasingly shifts to outpatient settings, ASCs are seeing significant growth in colonoscopy volume. Here are ten developments shaping that trend: ...

A biennial fecal immunochemical test-based CRC screening program can increase early-stage CRC detection and short-term survival.